BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6856622)

  • 1. Phenytoin teratogenicity in the primary and secondary mouse embryonic palate is influenced by the H-2 histocompatibility locus.
    Goldman AS; Fishman CL; Baker MK
    Proc Soc Exp Biol Med; 1983 May; 173(1):82-6. PubMed ID: 6856622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to phenytoin-induced cleft palate in mice is influenced by genes linked to H-2 and H-3.
    Goldman AS; Baker MK; Gasser DL
    Immunogenetics; 1983; 18(1):17-22. PubMed ID: 6862529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome scan for teratogen-induced clefting susceptibility loci in the mouse: evidence of both allelic and locus heterogeneity distinguishing cleft lip and cleft palate.
    Diehl SR; Erickson RP
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5231-6. PubMed ID: 9144220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to cleft palate and the major histocompatibility complex (H-2) in the mouse.
    Vekemans M; Fraser FC
    Teratology; 1982 Apr; 25(2):267-70. PubMed ID: 7101203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction fragment length polymorphisms, glucocorticoid receptors, and phenytoin-induced cleft palate in congenic strains of mice with steroid susceptibility differences.
    Gasser DL; Goldner-Sauvé A; Katsumata M; Goldman AS
    J Craniofac Genet Dev Biol; 1991; 11(4):366-71. PubMed ID: 1687470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major effects on teratogen-induced facial clefting in mice determined by a single genetic region.
    Karolyi J; Erickson RP; Liu S; Killewald L
    Genetics; 1990 Sep; 126(1):201-5. PubMed ID: 2227380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CORT-GR signal transduction pathway and CORT-induced cleft palate in H-2 congenic mice.
    Jaskoll T; Choy HA; Chen H; Melnick M
    J Craniofac Genet Dev Biol; 1995; 15(2):57-65. PubMed ID: 7635930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleft palate susceptibility maps in two H-2 subregions, H-2K to I-B and G to H-2D.
    Bonner JJ; Tyan ML
    J Immunogenet; 1982 Aug; 9(4):243-8. PubMed ID: 6811666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to phenytoin-induced cleft lip with or without cleft palate: many genes are involved.
    Karolyi IJ; Liu S; Erickson RP
    Genet Res; 1987 Feb; 49(1):43-9. PubMed ID: 3569906
    [No Abstract]   [Full Text] [Related]  

  • 10. H-2 histocompatibility region influences the inhibition of arachidonic acid cascade by dexamethasone and phenytoin in mouse embryonic palates.
    Gupta C; Katsumata M; Goldman AS
    J Craniofac Genet Dev Biol; 1985; 5(3):277-85. PubMed ID: 4044790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid-induced cleft palate in mice and H-2 haplotype: maternal and embryonic effects.
    Melnick M; Jaskoll T; Slavkin HC
    Immunogenetics; 1981; 13(5):443-50. PubMed ID: 7197664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazepam-induced cleft palate in the mouse and lack of correlation with the H-2 locus.
    Tocco DR; Renskers K; Zimmerman EF
    Teratology; 1987 Jun; 35(3):439-45. PubMed ID: 3629520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced cleft palate in the mouse: two major histocompatibility complex, H-2, loci with different mechanisms.
    Bonner JJ; Tyan ML
    Genetics; 1983 Feb; 103(2):263-76. PubMed ID: 6832582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal hyperoxia greatly reduces the incidence of phenytoin-induced cleft lip and palate in A/J mice.
    Millicovsky G; Johnston MC
    Science; 1981 May; 212(4495):671-2. PubMed ID: 7221553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of embryonic palatal shelf horizontalization and medial edge epithelial breakdown by cortisol: role of H-2 in the mouse.
    Goldman AS; Herold R; Piddington R
    J Craniofac Genet Dev Biol; 1988; 8(2):135-45. PubMed ID: 3182969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced cleft palate genes in chromosome 17: genetic linkage and mapping analyses.
    Bonner JJ; Tyan ML
    Immunogenetics; 1984; 20(2):169-83. PubMed ID: 6469287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical mechanism of glucocorticoid-and phenytoin-induced cleft palate.
    Goldman AS
    Curr Top Dev Biol; 1984; 19():217-39. PubMed ID: 6389029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speculations regarding the influence of the major histocompatibility complex (H-2) upon congenital craniofacial malformations in inbred and congenic strains of mice.
    Slavkin HC
    Birth Defects Orig Artic Ser; 1979; 15(8):43-54. PubMed ID: 518986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Backcross test demonstrates the linkage of glucocorticoid-induced cleft palate susceptibility to H-2.
    Bonner JJ; Tyan ML
    Teratology; 1982 Oct; 26(2):213-6. PubMed ID: 7157197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin A-enhanced cleft palate susceptibility associated with H-2.
    Tyan ML
    J Immunogenet; 1987; 14(4-5):239-45. PubMed ID: 3454798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.